Neurexis Therapeutics

Developer of therapeutic peptide for neuroprotective effect

placeAurora, Colorado, United States calendar_todayFounded 2020 groups3 employees language neurexistherapeutics.com

Social engagement

Social engagement: 301 social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include VIC Technology Venture Development.

Investor typeCountShare
Accelerator & incubator125%
Other / undisclosed375%

Recent activity

27 May 2026
Product launch
tatCN19o
Coming soon